Return

Bile Acids

Code:8053|CPT:82239|LOINC:14628-2

Synonyms
Анализ крови на желчные кислотыанализы для проверки поджелудочной железы и печенижелчные кислотыскрининг функций печени и поджелудочной железыBile acid testBile acidsBile acids blood testBile salt testGlyco and taurochenodeoxycholic acidLiver and pancreas function screening
IncludesBile Acids

Analysis details

Methodology

  • Enzymatic method
  • Enzymatic colorimetric method

Expected Turnaround Time

1 day

Special Instructions

How to use

The bile acid test (also known as the bile salt test) assesses the integrity of enterohepatic circulation across hepatocytes, the biliary tree, intestinal absorption, and portal venous return. Measuring total bile acids aids the diagnosis of cholestasis as part of liver function assessment, including intrahepatic cholestasis of pregnancy. In conjunction with routine liver chemistries, total bile acids assist in evaluating the activity of liver disease in diverse settings, including chronic viral hepatitis and cholestatic disorders.

Limitations

Bile acids are synthesized from cholesterol in hepatocytes, concentrated in the gallbladder, and released into the duodenum to facilitate emulsification and absorption of dietary lipids. Approximately 90% are reclaimed in the intestine and return to the liver through the portal vein, maintaining the enterohepatic pool and contributing to gut microbiome homeostasis. When bile formation or flow is impaired (cholestasis), bile acids accumulate in the bloodstream. Clinical manifestations can include pruritus that is often worse at night, jaundice, and fatigue. Cholestasis may be extrahepatic, as with ductal obstruction by stones or tumors, or intrahepatic due to hepatocellular or ductular disease. Reported causes include mechanical obstruction; hepatocellular dysfunction such as hepatitis or cirrhosis; genetic cholestatic syndromes (benign recurrent intrahepatic cholestasis, progressive familial intrahepatic cholestasis, ABCB4 deficiency, erythropoietic protoporphyria); biliary malformations (biliary hamartomas, Caroli syndrome); and parasitic infections (opisthorchiasis, fascioliasis, ascariasis, clonorchiasis, echinococcosis). Among laboratory measures for intrahepatic cholestasis of pregnancy, serum total bile acids are among the most sensitive; fasting concentrations ≥40 µmol/L have been associated with increased risks of preterm delivery and adverse perinatal outcomes. In this context, aminotransferase activities may be normal or only mildly elevated, while alkaline phosphatase is usually increased, although interpretation in pregnancy is limited by placental isoenzyme production.

Unitµmol/L
Reference interval
MinMax
012
IndicationsEvaluation when cholestasis is suspected, Assessment of suspected intrahepatic cholestasis of pregnancy, Workup of pruritus without an identified cause

Possible Causes of Abnormal Results

Increased levels

  • cholestatic liver disease
  • postprandial state

Specimen Requirements

SpecimenSerum
ContainerGold/Tiger Top (SST, Gel Separator)
Volume1 mL (min 0.2 mL)
Storage InstructionsRefrigerated, Frozen

References

Block E, Rutner H. Efficacy of postprandial bile acid levels as diagnostic tool for hepatobiliary disease. Clin Chem. 1979;25:1081. 31st National Meeting of the American Association for Clinical Chemistry, July 15-20, 1979, New Orleans, LA.

Korman MG, Hofmann AF, Summerskill WH. Assessment of activity in chronic liver disease: Serum bile acids compared with conventional tests and histology. N Engl J Med. 1974 Jun 20;290(25):1399-1402. PubMed 4133590.

Mashige F, Tanaka N, Maki A, Kamei S, Yamanaka M. Direct spectrophotometry of total bile acids in serum. Clin Chem. 1981 Aug;27(8):1352-1356.

Skrede S, Solberg HE, Blomhoff JP, Gjone E. Bile acids measured in serum during fasting as a test for liver disease. Clin Chem. 1978 Jul;24(7):1095-1099. PubMed 657487.

Savelieva GM, Sukhikh GT, Serov VN, Radzinsky VE, editors. Obstetrics: National Guideline. 2nd ed. Moscow: GEOTAR-Media; 2018.

Evsyutina YV, Ivashkin VT. Bile acid metabolism, liver diseases, and the microbiome. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(2):4-10.

Russian Society of Obstetricians and Gynecologists; Ministry of Health of the Russian Federation. Clinical guidelines: Intrahepatic cholestasis of pregnancy. 2020.

Lindor KD, Bowlus CL, Boyer J, et al. Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases. Hepatology. 2022;75:1012.

Burtis CA, Bruns DE. Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2014.

Gardiner FW, et al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review. Obstetric Medicine. 2019;12(3):123-128.

Ovadia C, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. The Lancet. 2019;393(10174):899-909.